Furazolidone and quinacrine. Comparative study of therapy for giardiasis in children

J. C. Craft, T. Murphy, J. D. Nelson

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Furazolidone and quinacrine hydrochloride were compared for efficacy, toxicity, and ease of administration in 45 young children with giardiasis. With the initial course of therapy, the cure rate was 89% (17/19) with furazolidone and with quinacrine it was 64% (9/14) in children less than 5 years and 92% (11/12) in older children. Cure rates for all courses of therapy were 92% (24/26) with furazolidone at 53% (/17) and 92% (12/13) in the younger and older children, respectively, treated with quinacrine. Quinacrine failure was usually due to severe vomiting. When re-treated with the furazolidone, patients were cured. The disadvantages of furazolidone are the large volume of doses and the expense. In this study, furazolidone was more effective and better tolerated than quinacrine for the treatment of giardiasis.

Original languageEnglish (US)
Pages (from-to)164-166
Number of pages3
JournalAmerican Journal of Diseases of Children
Volume135
Issue number2
StatePublished - 1981

Fingerprint

Furazolidone
Giardiasis
Quinacrine
Therapeutics
Vomiting

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Furazolidone and quinacrine. Comparative study of therapy for giardiasis in children. / Craft, J. C.; Murphy, T.; Nelson, J. D.

In: American Journal of Diseases of Children, Vol. 135, No. 2, 1981, p. 164-166.

Research output: Contribution to journalArticle

@article{5e74c802c6fc474b9ecb921ba03eac8f,
title = "Furazolidone and quinacrine. Comparative study of therapy for giardiasis in children",
abstract = "Furazolidone and quinacrine hydrochloride were compared for efficacy, toxicity, and ease of administration in 45 young children with giardiasis. With the initial course of therapy, the cure rate was 89{\%} (17/19) with furazolidone and with quinacrine it was 64{\%} (9/14) in children less than 5 years and 92{\%} (11/12) in older children. Cure rates for all courses of therapy were 92{\%} (24/26) with furazolidone at 53{\%} (/17) and 92{\%} (12/13) in the younger and older children, respectively, treated with quinacrine. Quinacrine failure was usually due to severe vomiting. When re-treated with the furazolidone, patients were cured. The disadvantages of furazolidone are the large volume of doses and the expense. In this study, furazolidone was more effective and better tolerated than quinacrine for the treatment of giardiasis.",
author = "Craft, {J. C.} and T. Murphy and Nelson, {J. D.}",
year = "1981",
language = "English (US)",
volume = "135",
pages = "164--166",
journal = "JAMA Pediatrics",
issn = "2168-6203",
publisher = "American Medical Association",
number = "2",

}

TY - JOUR

T1 - Furazolidone and quinacrine. Comparative study of therapy for giardiasis in children

AU - Craft, J. C.

AU - Murphy, T.

AU - Nelson, J. D.

PY - 1981

Y1 - 1981

N2 - Furazolidone and quinacrine hydrochloride were compared for efficacy, toxicity, and ease of administration in 45 young children with giardiasis. With the initial course of therapy, the cure rate was 89% (17/19) with furazolidone and with quinacrine it was 64% (9/14) in children less than 5 years and 92% (11/12) in older children. Cure rates for all courses of therapy were 92% (24/26) with furazolidone at 53% (/17) and 92% (12/13) in the younger and older children, respectively, treated with quinacrine. Quinacrine failure was usually due to severe vomiting. When re-treated with the furazolidone, patients were cured. The disadvantages of furazolidone are the large volume of doses and the expense. In this study, furazolidone was more effective and better tolerated than quinacrine for the treatment of giardiasis.

AB - Furazolidone and quinacrine hydrochloride were compared for efficacy, toxicity, and ease of administration in 45 young children with giardiasis. With the initial course of therapy, the cure rate was 89% (17/19) with furazolidone and with quinacrine it was 64% (9/14) in children less than 5 years and 92% (11/12) in older children. Cure rates for all courses of therapy were 92% (24/26) with furazolidone at 53% (/17) and 92% (12/13) in the younger and older children, respectively, treated with quinacrine. Quinacrine failure was usually due to severe vomiting. When re-treated with the furazolidone, patients were cured. The disadvantages of furazolidone are the large volume of doses and the expense. In this study, furazolidone was more effective and better tolerated than quinacrine for the treatment of giardiasis.

UR - http://www.scopus.com/inward/record.url?scp=0019378759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019378759&partnerID=8YFLogxK

M3 - Article

C2 - 7468550

AN - SCOPUS:0019378759

VL - 135

SP - 164

EP - 166

JO - JAMA Pediatrics

JF - JAMA Pediatrics

SN - 2168-6203

IS - 2

ER -